On the public citation graph

Preventing radiation induced xerostomia

0 signed · 89 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1001/archotol.130.8.956openalex-snapshot
Long-term Outcomes of Submandibular Gland Transfer for Prevention of Postradiation Xerostomia
inferredcites →https://doi.org/10.1002/(sici)1097-0347(199705)19:3<169::aid-hed1>3.0.co;2-0openalex-snapshot
Detailed quality of life assessment in patients treated with primary radiotherapy for squamous cell cancer of the base of the tongue
inferredcites →https://doi.org/10.1002/1097-0142(19870315)59:6<1123::aid-cncr2820590614>3.0.co;2-xopenalex-snapshot
Effectiveness of pilocarpine in postradiation xerostomia
inferredcites →https://doi.org/10.1002/1097-0142(19930301)71:5<1848::aid-cncr2820710522>3.0.co;2-fopenalex-snapshot
Use of pilocarpine during head and neck radiation therapy to reduce xerostomia and salivary dysfunction
inferredcites →https://doi.org/10.1002/cncr.20552openalex-snapshot
Intensity‐modulated radiotherapy for early‐stage nasopharyngeal carcinoma
inferredcites →https://doi.org/10.1002/jso.2930420414openalex-snapshot
Treatment of radiation side effects with oral pilocarpine
inferredcites →https://doi.org/10.1007/s00066-003-1016-1openalex-snapshot
Randomized Phase III Trial of Postoperative Radiochemotherapy ± Amifostine in Head and Neck Cancer
inferredcites →https://doi.org/10.1016/0167-8140(92)90252-popenalex-snapshot
Treatment acceleration in radiotherapy: the relative time factors and dose-response slopes for tumours and normal tissues
inferredcites →https://doi.org/10.1016/0167-8140(94)01491-kopenalex-snapshot
Effects of continuous hyperfractionated accelerated and conventionally fractionated radiotherapy on the parotid and submandibular salivary glands of rhesus monkeys
inferredcites →https://doi.org/10.1016/0360-3016(84)90496-6openalex-snapshot
Dephosphorylation of WR-2721 with mouse tissue homogenates
inferredcites →https://doi.org/10.1016/0360-3016(89)90503-8openalex-snapshot
Dose fractionation and regeneration in radiotherapy for cancer of the oral cavity and oropharynx: Tumor dose-response and repopulation
inferredcites →https://doi.org/10.1016/0360-3016(93)90143-jopenalex-snapshot
Major salivary gland function in patients with radiation-induced xerostomia: Flow rates and sialochemistry
inferredcites →https://doi.org/10.1016/j.ijrobp.2003.10.005openalex-snapshot
Effects of amifostine on acute toxicity from concurrent chemotherapy and radiotherapy for inoperable non–small-cell lung cancer: report of a randomized comparative trial
inferredcites →https://doi.org/10.1016/j.ijrobp.2004.03.010openalex-snapshot
Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II—clinical results
inferredcites →https://doi.org/10.1016/j.ijrobp.2004.07.419openalex-snapshot
Xerostomia quality of life in head and neck cancer patients who are beyond the acute recovery phase following radiotherapy: IMRT versus conventional radiotherapy
inferredcites →https://doi.org/10.1016/j.ijrobp.2004.08.001openalex-snapshot
Postradiotherapy quality of life for head-and-neck cancer patients is independent of xerostomia
inferredcites →https://doi.org/10.1016/s0093-7754(02)70002-xopenalex-snapshot
Preclinical studies on the radioprotective efficacy and pharmacokinetics of subcutaneously administered amifostine
inferredcites →https://doi.org/10.1016/s0093-7754(02)70004-3openalex-snapshot
Down-regulation of intestinal-type alkaline phosphatase in the tumor vasculature and stroma provides a strong basis for explaining amifostine selectivity
inferredcites →https://doi.org/10.1016/s0093-7754(02)70009-2openalex-snapshot
Hypofractionated and accelerated radiotherapy with amifostine cytoprotection (HypoARC): A new concept in radiotherapy and encouraging results in breast cancer
inferredcites →https://doi.org/10.1016/s0167-8140(97)00079-0openalex-snapshot
Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: results of the EORTC 22851 randomized trial
inferredcites →https://doi.org/10.1016/s0167-8140(97)00094-7openalex-snapshot
A randomised multicentre trial of CHART versus conventional radiotherapy in head and neck cancer
inferredcites →https://doi.org/10.1016/s0360-3016(00)00735-5openalex-snapshot
Effect of amifostine on patient assessed clinical benefit in irradiated head and neck cancer
inferredcites →https://doi.org/10.1016/s0360-3016(00)00768-9openalex-snapshot
Protective effect of amifostine on dental health after radiotherapy of the head and neck
inferredcites →https://doi.org/10.1016/s0360-3016(00)01441-3openalex-snapshot
A prospective study of salivary function sparing in patients with head-and-neck cancers receiving intensity-modulated or three-dimensional radiation therapy: initial results
inferredcites →https://doi.org/10.1016/s0360-3016(01)01749-7openalex-snapshot
Intensity-modulated radiotherapy: current status and issues of interest
inferredcites →https://doi.org/10.1016/s0360-3016(01)02683-9openalex-snapshot
Prophylactic use of amifostine to prevent radiochemotherapy-induced mucositis and xerostomia in head-and-neck cancer
inferredcites →https://doi.org/10.1016/s0360-3016(02)02724-4openalex-snapshot
Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience
inferredcites →https://doi.org/10.1016/s0360-3016(02)02890-0openalex-snapshot
A Phase III placebo-controlled trial of oral pilocarpine in patients undergoing radiotherapy for head-and-neck cancer
inferredcites →https://doi.org/10.1016/s0360-3016(03)00121-4openalex-snapshot
Phase III quality-of-life study results: impact on patients’ quality of life to reducing xerostomia after radiotherapy for head-and-neck cancer—RTOG 97-09
inferredcites →https://doi.org/10.1016/s0360-3016(03)00415-2openalex-snapshot
Oropharyngeal candidiasis caused by non-albicans yeast in patients receiving external beam radiotherapy for head-and-neck cancer
inferredcites →https://doi.org/10.1016/s0360-3016(03)01437-8openalex-snapshot
Evaluation of salivary gland function after treatment of head-and-neck tumors with intensity-modulated radiotherapy by quantitative pertechnetate scintigraphy
inferredcites →https://doi.org/10.1016/s0360-3016(03)01571-2openalex-snapshot
Preservation of oral health–related quality of life and salivary flow rates after inverse-planned intensity- modulated radiotherapy (IMRT) for head-and-neck cancer
inferredcites →https://doi.org/10.1016/s0360-3016(03)01627-4openalex-snapshot
A multinational, randomized phase iii trial of iseganan hcl oral solution for reducing the severity of oral mucositis in patients receiving radiotherapy for head-and-neck malignancy
inferredcites →https://doi.org/10.1016/s0360-3016(99)00128-5openalex-snapshot
Quality of life in patients cured from a carcinoma of the head and neck by radiotherapy: the importance of the target volume
inferredcites →https://doi.org/10.1016/s0360-3016(99)00460-5openalex-snapshot
Submandibular salivary gland transfer prevents radiation-induced xerostomia
inferredcites →https://doi.org/10.1016/s0360-3016(99)00532-5openalex-snapshot
A randomized study of very accelerated radiotherapy with and without amifostine in head and neck squamous cell carcinoma
inferredcites →https://doi.org/10.1016/s0889-8588(03)00145-xopenalex-snapshot
Radiation and third-generation chemotherapy
inferredcites →https://doi.org/10.1016/s1098-3015(11)71002-6openalex-snapshot
PCD13: PATIENT BENEFIT QUESTIONNAIRE (PBQ) FOR XEROSTOMIA: DEVELOPMENT AND VALIDATION REPORT
inferredcites →https://doi.org/10.1016/s1357-4310(99)01615-9openalex-snapshot
Causes and consequences of tumour acidity and implications for treatment
inferredcites →https://doi.org/10.1016/s1368-8375(02)00144-6openalex-snapshot
Oral candidiasis in head and neck cancer patients receiving radiotherapy with amifostine cytoprotection
inferredcites →https://doi.org/10.1023/a:1008282412670openalex-snapshot
Selective cytoprotection with amifostine in concurrent radiochemotherapy for head and neck cancer
inferredcites →https://doi.org/10.1038/sj.bjc.6600486openalex-snapshot
Concurrent administration of Docetaxel and Stealth® liposomal doxorubicin with radiotherapy in non-small cell lung cancer : excellent tolerance using subcutaneous amifostine for cytoprotection
inferredcites →https://doi.org/10.1053/j.seminoncol.2003.11.014openalex-snapshot
Amifostine: is there evidence of tumor protection?
inferredcites →https://doi.org/10.1053/sonc.2002.37355openalex-snapshot
Preclinical studies on the radioprotective efficacy and pharmacokinetics of subcutaneously administered amifostine
inferredcites →https://doi.org/10.1053/sonc.2002.37356openalex-snapshot
Down-regulation of intestinal-type alkaline phosphatase in the tumor vasculature and stroma provides a strong basis for explaining amifostine selectivity
inferredcites →https://doi.org/10.1053/sonc.2002.37359openalex-snapshot
Hypofractionated and accelerated radiotherapy with amifostine cytoprotection (HypoARC): A new concept in radiotherapy and encouraging results in breast cancer
inferredcites →https://doi.org/10.1097/00001813-200203000-00001openalex-snapshot
Amifostine in clinical oncology: current use and future applications
inferredcites →https://doi.org/10.1097/00005537-200102000-00028openalex-snapshot
Submandibular Gland Transfer: A New Method of Preventing Radiation‐Induced Xerostomia
inferredcites →https://doi.org/10.1159/000067145openalex-snapshot
New Chemotherapeutic Agents: Update of Major Chemoradiation Trials in Solid Tumors
inferredcites →https://doi.org/10.1185/03007999809113355openalex-snapshot
A Pilot Study of Salix SST (Saliva-stimulating Lozenges) in Post-irradiation Xerostomia
inferredcites →https://doi.org/10.1200/jco.1993.11.6.1124openalex-snapshot
A multicenter, randomized, double-blind, placebo-controlled, dose-titration study of oral pilocarpine for treatment of radiation-induced xerostomia in head and neck cancer patients.
inferredcites →https://doi.org/10.1200/jco.1998.16.11.3542openalex-snapshot
Salivary gland protection by amifostine in high-dose radioiodine treatment: results of a double-blind placebo-controlled study.
inferredcites →https://doi.org/10.1200/jco.2000.18.11.2226openalex-snapshot
Subcutaneous Administration of Amifostine During Fractionated Radiotherapy: A Randomized Phase II Study
inferredcites →https://doi.org/10.1200/jco.2000.18.19.3339openalex-snapshot
Phase III Randomized Trial of Amifostine as a Radioprotector in Head and Neck Cancer
inferredcites →https://doi.org/10.1200/jco.2002.04.178openalex-snapshot
2002 Update of Recommendations for the Use of Chemotherapy and Radiotherapy Protectants: Clinical Practice Guidelines of the American Society of Clinical Oncology
inferredcites →https://doi.org/10.1667/0033-7587(2002)158[0115:imrt]2.0.co;2openalex-snapshot
Intensity-Modulated Radiation Therapy
inferredcites →https://doi.org/10.2307/3576875openalex-snapshot
Hydrolysis of WR2721 by Mouse Liver Cell Fractions
inferredcites →https://doi.org/10.3109/02841869409083923openalex-snapshot
Influence of Late Side-Effects Upon Daily Life After Radiotherapy for Laryngeal and Pharyngeal Cancer
inferredcites →https://doi.org/10.3109/02841869609101661openalex-snapshot
Head and Neck Cancer
inferredcites →https://doi.org/10.3109/03602538908994143openalex-snapshot
Radiation Protectors: the Unexpected Benefits

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.4778661openalex-extracted
Oral Superoxide Dismutase Prevents Radiation Enteritis
inferred← citeshttps://doi.org/10.1001/archoto.2012.226openalex-snapshot
Radiotherapy in Parotid Acinic Cell Carcinoma
inferred← citeshttps://doi.org/10.1007/978-3-030-04702-3_20openalex-snapshot
Acute and Long-Term Effects of Chemoradiation Therapy in Head and Neck Cancer
inferred← citeshttps://doi.org/10.1007/978-3-540-47072-4_23openalex-snapshot
Temporal Bone Resection
inferred← citeshttps://doi.org/10.1016/b978-0-7216-0261-5.50023-5openalex-snapshot
Management of Opioid-Related Side Effects
inferred← citeshttps://doi.org/10.1016/b978-1-4160-4665-3.00003-2openalex-snapshot
Malignancies of the Temporal Bone—Limited Temporal Bone Resection
inferred← citeshttps://doi.org/10.1016/j.gce.2026.04.002openalex-snapshot
Bioinspired engineering of simplified Type I photosensitizers against hypoxic oral squamous cell carcinoma
inferred← citeshttps://doi.org/10.1016/j.heliyon.2024.e31005openalex-snapshot
Dicliptera chinensis-derived polysaccharide enhanced the growth activity of submandibular gland cells in vitro after radiotherapy
inferred← citeshttps://doi.org/10.1016/j.ijrobp.2007.04.021openalex-snapshot
Impact of Radiation-Induced Xerostomia on Quality of Life After Primary Radiotherapy Among Patients With Head and Neck Cancer
inferred← citeshttps://doi.org/10.1016/j.jpainsymman.2007.09.009openalex-snapshot
Assessment of Xerostomia and Its Impact on Quality of Life in Head and Neck Cancer Patients Undergoing Radiotherapy, and Validation of the Taiwanese Version of the Xerostomia Questionnaire
inferred← citeshttps://doi.org/10.1016/j.oraloncology.2010.03.008openalex-snapshot
Xerostomia in head and neck malignancy
inferred← citeshttps://doi.org/10.1016/j.radi.2009.01.002openalex-snapshot
A survey of techniques to reduce and manage external beam radiation-induced xerostomia in British oncology and radiotherapy departments
inferred← citeshttps://doi.org/10.1016/j.radi.2013.02.006openalex-snapshot
A national survey of supportive practices for patients undergoing radiotherapy for oral cancers
inferred← citeshttps://doi.org/10.1016/j.tripleo.2006.11.013openalex-snapshot
Management of salivary hypofunction during and after radiotherapy
inferred← citeshttps://doi.org/10.1016/s1808-8694(15)30520-6openalex-snapshot
Analysis of the Cytoprotective Effect of Amifostine on the Irradiated Inner Ear of Guinea Pigs: An Experimental Study
inferred← citeshttps://doi.org/10.1038/gt.2010.142openalex-snapshot
Adenoviral delivery of Tousled kinase for the protection of salivary glands against ionizing radiation damage
inferred← citeshttps://doi.org/10.1038/s41598-022-12581-yopenalex-snapshot
Radioprotective effects and mechanism of HL-003 on radiation-induced salivary gland damage in mice
inferred← citeshttps://doi.org/10.1080/17425247.2025.2569641openalex-snapshot
Drug and stem cells delivery to salivary glands – a concise review
inferred← citeshttps://doi.org/10.1089/acm.2007.0793openalex-snapshot
Manual Acupuncture Improved Quality of Life in Cancer Patients with Radiation-Induced Xerostomia
inferred← citeshttps://doi.org/10.1097/mjt.0b013e3181c960dcopenalex-snapshot
Risk of Xerostomia in Association With the Receipt of Radiation Therapy in Older Patients With Head and Neck Cancer
inferred← citeshttps://doi.org/10.1111/j.1600-0757.2011.00394.xopenalex-snapshot
Oral cancers: supportive care issues
inferred← citeshttps://doi.org/10.1179/096992608x296932openalex-snapshot
Management of xerostomia and salivary hypofunction
inferred← citeshttps://doi.org/10.1590/s1806-83242011000200014openalex-snapshot
Acupuncture for the prevention of radiation-induced xerostomia in patients with head and neck cancer
inferred← citeshttps://doi.org/10.17650/3034-2473-2026-3-1-43-50openalex-snapshot
Management of patients with head and neck cancer undergoing radiation or chemoradiation therapy: from prevention to monitoring
inferred← citeshttps://doi.org/10.2217/fon.13.79openalex-snapshot
Radioprotective Agents for the Prevention of Side Effects Induced by Radioiodine-131 Therapy
inferred← citeshttps://doi.org/10.3322/caac.21157openalex-snapshot
Oral complications of cancer and cancer therapy
inferred← citeshttps://doi.org/10.4314/tmj.v30i1.285openalex-snapshot
Oral and otolaryngological complications of radiotherapy for head and neck cancers among patients attending Ocean Road Cancer Institute, Tanzania
inferred← citeshttps://doi.org/10.5681/joddd.2007.011openalex-snapshot
Evaluation of Radiation-induced Xerostomia in Patients with Nasopharyngeal Carcinomas
inferred← citeshttps://doi.org/10.5681/joddd.2008.017openalex-snapshot
Evaluation of radiation-induced Class V dental caries in patients with head and neck cancers undergoing radiotherapy
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.